Rigel Pharmaceuticals reported $59.28M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acceleron Pharma XLRN:US $ 57.37M 2.11M
Acura Pharmaceuticals ACUR:US 1.11M 6.57M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Amgen AMGN:US $ 14842M 257M
Anika Therapeutics ANIK:US $ 28.77M 12.6M
Applied Genetic Technologies AGTC:US $ 21.71M 2M
Arrowhead Research ARWR:US $ 146.54M 48.9M
Astrazeneca AZN:US $ 23649M 1427M
AstraZeneca AZN:LN 23649M 1427M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Celldex Therapeutics CLDX:US $ 14.18M 0.31M
Chemocentryx CCXI:US $ 60.03M 4.65M
Daiichi Sankyo 4568:JP Y 336046M 3275M
Dicerna Pharmaceuticals DRNA:US $ 239.3M 31.64M
Eli Lilly And LLY:US $ 13682M 1411.2M
Flexion Therapeutics FLXN:US $ 43.99M 4.06M
Halozyme Therapeutics HALO:US $ 113.15M 1.1M
Heron Therapeutics HRTX:US $ 72.3M 9.85M
Immunogen IMGN:US $ 111.78M 8.53M
Intrexon XON:US $ 28.99M 0.12M
IONIS PHARMACEUT IONS:US $ 218M 75.82M
Karyopharm Therapeutics KPTI:US $ 68.87M 10.74M
Ligand Pharmaceuticals LGND:US $ 36.3M 16.2M
Macrogenics MGNX:US $ 68.86M 1.06M
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Rigel Pharmaceuticals RIGL:US $ 59.28M 0.26M
Sangamo Biosciences SGMO:US $ 131.9M 5.04M
Ultragenyx Pharmaceutical RARE:US $ 135.93M 8.87M
Veracyte VCYT:US $ 50.04M 13.93M